SLC40A1 and Abnormality of the skin: In summary, we present evidence that iron participates in Omniscan-induced differentiation of PBMC into ferroportin-expressing cells, and that chelation of iron with deferiprone therapy is effective in preventing Omniscan-induced NSF-like skin changes in mice.